![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Malignant Melanoma |
Free Subscription
1 Am J Dermatopathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Malignant Melanoma is free of charge.
Spitz Melanoma With SLC20A1::ALK Fusion: A Novel Fusion Previously Undescribed in
Spitz Melanocytic Neoplasm.
Am J Dermatopathol. 2024 Jun 28. doi: 10.1097/DAD.0000000000002778.
PubMed
Abstract available
ASO Visual Abstract: Impact of an Online Risk Calculator for Sentinel Node
Positivity on Management of Patients with T1 and T2 Melanomas.
Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15636.
PubMed
ASO Author Reflections: Distilling Wisdom From Two Decades of Cutaneous Malignant
Melanoma at a Peruvian Cancer Institute: A Stirring Call for Action.
Ann Surg Oncol. 2024 Jul 2. doi: 10.1245/s10434-024-15672.
PubMed
Intraparotid Sentinel Lymph Node Dissection for Melanoma: A Systematic Review and
Meta-Analysis.
Ann Surg Oncol. 2024 Jul 2. doi: 10.1245/s10434-024-15668.
PubMed
Abstract available
Interdisciplinary Implementation of a Synoptic Reporting Template for Melanoma
Nodal Surveillance Ultrasound.
Ann Surg Oncol. 2024 Jul 2. doi: 10.1245/s10434-024-15630.
PubMed
Abstract available
Patterns and trends in melanoma mortality in the United States, 1999-2020.
BMC Cancer. 2024;24:790.
PubMed
Abstract available
JAAD Game Changers: "Functional surgery versus amputation for in situ or
minimally invasive nail melanoma: A meta-analysis".
J Am Acad Dermatol. 2024 Jun 29:S0190-9622(24)00983.
PubMed
JAAD Game Changers: "Melanoma-associated leukoderma and vitiligo cannot be
differentiated based on blinded assessment by experts in the field".
J Am Acad Dermatol. 2024 Jun 29:S0190-9622(24)00985.
PubMed
Clinicopathologically Defined Naevus Subtypes and Melanoma Risk.
J Invest Dermatol. 2024 Jun 26:S0022-202X(24)01868.
PubMed
Abstract available
Efficacy of axitinib in a US cohort of patients with programmed cell death
protein 1-resistant mucosal melanoma.
Melanoma Res. 2024 Jun 28. doi: 10.1097/CMR.0000000000000988.
PubMed
Abstract available
Interfering with aggregated alpha-synuclein in advanced melanoma leads to a major
upregulation of MHC class II proteins.
Melanoma Res. 2024 Jul 2. doi: 10.1097/CMR.0000000000000982.
PubMed
Abstract available
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma
Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
PLoS One. 2024;19:e0306658.
PubMed
Abstract available
Thank you for your interest in scientific medicine.